Metraipolis › archive › dc_3e5fe06e5876

QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41333851
DOI
10.3389/fbinf.2025.1663846
License (as archived)
solo-consultazione
Archived
2026-11-08T12:19:47.236Z
SHA-256 of the archived text
218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387
Stable URL of this page
https://metraipolis.com/documento/dc_3e5fe06e5876

How to cite

QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851 — Europe PMC (en), https://europepmc.org/article/MED/41333851 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3e5fe06e5876 (Metraipolis archive dc_3e5fe06e5876, sha256 218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387)
BibTeX
@misc{dc3e5fe06e5876,
  title = {QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy — Europe PMC PMID:41333851},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41333851},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3e5fe06e5876; sha256 218750df398aec837d7dafe7c784282293953c320339953092e85ed5591ff387},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333851. Agents can read the archived copy with the MCP tool read_document.